Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

The Role of Heterozygous Variants in SAMD9/9L and Recessive Bone Marrow Failure-Related Genes in Adults with Severe Aplastic Anemia

Dalton Hironaka, Xiaoyang Ma, Bhavisha A. Patel, Emma M. Groarke, Jennifer Lotter, Olga Rios, Juan L Coelho-Silva, Colin O. Wu, Jorg Cammenga, Fernanda Gutierrez-Rodrigues, Neal S. Young

Blood (2022) 140 (Supplement 1): 479–480.

https://doi.org/10.1182/blood-2022-162886

Published: 2022

Journal Articles

Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers; The Prospective Nordic Study NMDSG14B

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-138782

Published: 2020

Journal Articles

Impact of Donor-Derived CD34+ Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 3338.

https://doi.org/10.1182/blood-2019-123827

Published: 2019

Journal Articles

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

Gunnar Juliusson, Oskar Hagberg, Vladimir Lj Lazarevic, Emma Ölander, Petar Antunovic, Jörg Cammenga, Lovisa Wennström, Lars Möllgård, Mats Brune, Martin Jädersten, Stefan Deneberg, Sören Lehmann, Åsa Rangert Derolf, Martin Höglund

Blood (2019) 134 (18): 1558–1561.

https://doi.org/10.1182/blood.2019001728

Published: 2019

Includes: Supplemental data

Journal Articles

Opposing Pathogenesis of Germline SAMD9/SAMD9L Variants in Adult Myelodysplastic Syndrome (MDS)

Blood (2018) 132 (Supplement 1): 4351.

https://doi.org/10.1182/blood-2018-99-119896

Published: 2018

Journal Articles

Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes

Blood (2018) 132 (21): 2309–2313.

https://doi.org/10.1182/blood-2017-05-787390

Published: 2018

Includes: Supplemental data

Journal Articles

Germline SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes

Yasunobu Nagata, MD PhD, Bartlomiej P. Przychodzen, MSc, Cassandra M. Hirsch, BS, Hideki Makishima, MD PhD, Victor Pastor Loyola, MSc, Babal K Jha, PhD, Teodora Kuzmanovic, BA, Tomas Radivoyevitch, PhD, Vera Adema, PhD, Kenichi Yoshida, MD PhD, Samuel Li, BA, Francesc Sole, PhD, Thomas Laframboise, PhD, Rabi Hanna, MD, Mikkael A. Sekeres, MD MS, Seishi Ogawa, MD PhD, Marcin W. Wlodarski, MD PhD, Jorg Cammenga, MD, Jaroslaw P. Maciejewski, PhD MD FACP

Blood (2017) 130 (Supplement 1): 1670.

https://doi.org/10.1182/blood.V130.Suppl_1.1670.1670

Published: 2017

Journal Articles

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms

Blood (2017) 129 (16): 2266–2279.

https://doi.org/10.1182/blood-2016-10-743302

Published: 2017

Includes: Supplemental data

Journal Articles

Cytopenia, Predisposition to Myelodysplastic Syndrome, Immunodeficiency, and Neurological Disease Caused By Gain-of-Function SAMD9L Mutations Is Frequently Ameliorated By Hematopoietic Revertant Mosaicism

Blood (2016) 128 (22): 4299.

https://doi.org/10.1182/blood.V128.22.4299.4299

Published: 2016

Journal Articles

Up-Regulation of Flt3 Is a Passive Event in Hoxa9/Meis1-Induced Acute Myeloid Leukemia

Anna Staffas, PhD, Yuan Wei, MD PhD, Laleh Arabanian, Ann Jansson, Sara Ståhlman, Susanne Li, Linda Fogelstrand, MD PhD, Jörg Cammenga, MD PhD, Florian Kuchenbauer, MD PhD, Lars Palmqvist, MD PhD

Blood (2015) 126 (23): 2441.

https://doi.org/10.1182/blood.V126.23.2441.2441

Published: 2015

Journal Articles

Tumor Suppressor Role of HIF-1alpha in Leukemia-Initiating Cells in Flt3-ITD-Induced Myeloproliferative Neoplasm

Talia Velasco, PhD, Jörg Cammenga, MD

Blood (2014) 124 (21): 3578.

https://doi.org/10.1182/blood.V124.21.3578.3578

Published: 2014

Journal Articles

Hematopoietic Stem Cells Are Intrinsically Protected Against MLL-ENL Mediated Transformation

Amol Sanjay Ugale, Gudmundur Logi Norddahl, Martin Wahlestedt, Petter Säwén, Pekka Jaako, PhD, Cornelis J.H. Pronk, MDPhD, Shamit Soneji, PhD, Jorg Cammenga, MD PhD, David Bryder, PhD

Blood (2014) 124 (21): 839.

https://doi.org/10.1182/blood.V124.21.839.839

Published: 2014

Journal Articles

HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia

Talia Velasco-Hernandez, Axel Hyrenius-Wittsten, Matilda Rehn, David Bryder, Jörg Cammenga

Blood (2014) 124 (24): 3597–3607.

https://doi.org/10.1182/blood-2014-04-567065

Published: 2014

Includes: Supplemental data

Journal Articles

Molecular and Cellular Effects of Oncogene Cooperation in a Genetically Adequate AML Model

Kristian Reckzeh, Oxana Bereshchenko, Adam J. Mead, M.D., Ph.D., Matilda Rehn, Shabnam Kharazi, Sten Eirik W Jacobsen, M.D., Ph.D., Claus Nerlov, Ph.D., Jorg Cammenga, M.D., Ph.D.

Blood (2011) 118 (21): 1379.

https://doi.org/10.1182/blood.V118.21.1379.1379

Published: 2011

Journal Articles

Hypoxic Induction of Vascular Endothelial Growth Factor Regulates Fetal Erythropoiesis but Not Stem Cell Function

Matilda Rehn, Jorg Cammenga, M.D., Ph.D.

Blood (2011) 118 (21): 4823.

https://doi.org/10.1182/blood.V118.21.4823.4823

Published: 2011

Journal Articles

Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD –induced myeloproliferation

Shabnam Kharazi, Adam J. Mead, Anna Mansour, Anne Hultquist, Charlotta Böiers, Sidinh Luc, Natalija Buza-Vidas, Zhi Ma, Helen Ferry, Debbie Atkinson, Kristian Reckzeh, Kristina Masson, Jörg Cammenga, Lars Rönnstrand, Fumio Arai, Toshio Suda, Claus Nerlov, Ewa Sitnicka, Sten Eirik W. Jacobsen

Blood (2011) 118 (13): 3613–3621.

https://doi.org/10.1182/blood-2010-06-289207

Published: 2011

Includes: Supplemental data

Journal Articles

Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche

Matilda Rehn, André Olsson, Kristian Reckzeh, Eva Diffner, Peter Carmeliet, Göran Landberg, Jörg Cammenga

Blood (2011) 118 (6): 1534–1543.

https://doi.org/10.1182/blood-2011-01-332890

Published: 2011

Includes: Supplemental data

Journal Articles

Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation

Ronan Quéré, Göran Karlsson, Falk Hertwig, Marianne Rissler, Beata Lindqvist, Thoas Fioretos, Peter Vandenberghe, Marilyn L. Slovak, Jörg Cammenga, Stefan Karlsson

Blood (2011) 117 (22): 5918–5930.

https://doi.org/10.1182/blood-2010-08-301879

Published: 2011

Includes: Supplemental data

Journal Articles

Down-Regulation of CEBPA Expression Has a Stronger Impact on Myeloid Differentiation in Human Versus Mouse Cells: Mechanistic Implications for CEBPA Mutations in AML.

Gabriela Bernadeta Iwanski, MD, Birte Niebuhr, Maike Täger, PhD, Susanne Roscher, Carol Stocking, PhD, Jorg Cammenga, MD

Blood (2008) 112 (11): 1372.

https://doi.org/10.1182/blood.V112.11.1372.1372

Published: 2008

Journal Articles

Smad4 as a Therapeutic Target in Nup98-HoxA9-Induced Leukemia.

Ronan Quere, Ph.D., Goran Karlsson, Ph.D., Silja Andradottir, Marianne Rissler, Karin Olsson, Falk Hertwig, Kristian Reckzeh, MSc, Jorg Cammenga, MD, Ph.D., Stefan Karlsson, MD, Ph.D.

Blood (2008) 112 (11): 1799.

https://doi.org/10.1182/blood.V112.11.1799.1799

Published: 2008

NARROW

The Role of Heterozygous Variants in SAMD9/9L and Recessive Bone Marrow Failure-Related Genes in Adults with Severe Aplastic Anemia

Prediction of Relapse after Allogeneic Stem Cell Transplantation Using Individualized Minimal Residual Markers; The Prospective Nordic Study NMDSG14B

Impact of Donor-Derived CD34+ Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT

Improved survival of men 50 to 75 years old with acute myeloid leukemia over a 20-year period

Opposing Pathogenesis of Germline SAMD9/SAMD9L Variants in Adult Myelodysplastic Syndrome (MDS)

Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes

Germline SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes

Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms

Cytopenia, Predisposition to Myelodysplastic Syndrome, Immunodeficiency, and Neurological Disease Caused By Gain-of-Function SAMD9L Mutations Is Frequently Ameliorated By Hematopoietic Revertant Mosaicism

Up-Regulation of Flt3 Is a Passive Event in Hoxa9/Meis1-Induced Acute Myeloid Leukemia

Tumor Suppressor Role of HIF-1alpha in Leukemia-Initiating Cells in Flt3-ITD-Induced Myeloproliferative Neoplasm

Hematopoietic Stem Cells Are Intrinsically Protected Against MLL-ENL Mediated Transformation

HIF-1α can act as a tumor suppressor gene in murine acute myeloid leukemia

Molecular and Cellular Effects of Oncogene Cooperation in a Genetically Adequate AML Model

Hypoxic Induction of Vascular Endothelial Growth Factor Regulates Fetal Erythropoiesis but Not Stem Cell Function

Impact of gene dosage, loss of wild-type allele, and FLT3 ligand on Flt3-ITD –induced myeloproliferation

Hypoxic induction of vascular endothelial growth factor regulates murine hematopoietic stem cell function in the low-oxygenic niche

Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation

Down-Regulation of CEBPA Expression Has a Stronger Impact on Myeloid Differentiation in Human Versus Mouse Cells: Mechanistic Implications for CEBPA Mutations in AML.

Smad4 as a Therapeutic Target in Nup98-HoxA9-Induced Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only